Evidence map›Paper›PMID 41507382›Full record

ArticleBone marrow transplantation2026

Can modified lymphodepletion before tisagenlecleucel improve outcome in high-risk patients with large B-cell lymphoma?

Marta Canelo-Vilaseca, Mohamad Sabbah, Caterina Cristinelli, Côme Bommier, Pierre Sesques, Mikael Roussel, Pierre Bories, Vincent Allain, Amani Ouedrani, Ilenia De Bernardis and 16 more

Erratum issuedAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Bone marrow transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors.

Marta Canelo-VilasecaAssistance Publique - Hôpitaux de Paris, Hôpital Saint Louis, Hemato-oncologie, Paris, France.ORCID http://orcid.org/0000-0003-4479-4925
Mohamad SabbahAssistance Publique - Hôpitaux de Paris, Hôpital Saint Louis, Hemato-oncologie, Paris, France.
Caterina CristinelliAssistance Publique - Hôpitaux de Paris, Hôpital Saint Louis, Hemato-oncologie, Paris, France.
Côme BommierAssistance Publique - Hôpitaux de Paris, Hôpital Saint Louis, Hemato-oncologie, Paris, France.
Pierre SesquesHospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Service d'Hématologie, Lyon, Pierre Bénite Cedex, France.
Mikael RousselHematology Department, CHU de Rennes, Rennes, France.
Pierre BoriesHematology Department, CHU de Toulouse, Toulouse, France.
Vincent AllainUniversité Paris Cité, Paris, France.
Amani OuedraniAssistance Publique - Hôpitaux de Paris, Hôpital Saint Louis, Immunologie, Paris, France.
Ilenia De BernardisAssistance Publique - Hôpitaux de Paris, Hôpital Saint Louis, Hemato-oncologie, Paris, France.
Agathe VelyAssistance Publique - Hôpitaux de Paris, Hôpital Saint Louis, Hemato-oncologie, Paris, France.
Pierre StephanAssistance Publique - Hôpitaux de Paris, Hôpital Saint Louis, Hemato-oncologie, Paris, France.ORCID http://orcid.org/0000-0001-5999-284X
Laetitia VercellinoUniversité Paris Cité, Paris, France.
Fabienne VenetHospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Service d'Hématologie, Lyon, Pierre Bénite Cedex, France.
Rémi PescarmonaHospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Service d'Hématologie, Lyon, Pierre Bénite Cedex, France.
Roch HouotHematology Department, CHU de Rennes, Rennes, France.
François VergezHematology Department, CHU de Toulouse, Toulouse, France.
Romain de JornaAssistance Publique - Hôpitaux de Paris, Hôpital Saint Louis, Pharmacie, Paris, France.
Isabelle MadelaineAssistance Publique - Hôpitaux de Paris, Hôpital Saint Louis, Pharmacie, Paris, France.
Nathalie ParquetAssistance Publique - Hôpitaux de Paris, Hôpital Saint Louis, Aphérèse thérapeutique, Paris, France.
Anne C BrignierAssistance Publique - Hôpitaux de Paris, Hôpital Saint Louis, Aphérèse thérapeutique, Paris, France.
Jérôme LargheroUniversité Paris Cité, Paris, France.
Miryam MebarkiUniversité Paris Cité, Paris, France.
Roberta Di BlasiAssistance Publique - Hôpitaux de Paris, Hôpital Saint Louis, Hemato-oncologie, Paris, France.
Sophie Caillat-ZucmanUniversité Paris Cité, Paris, France.ORCID http://orcid.org/0000-0002-4535-3550
Catherine ThieblemontAssistance Publique - Hôpitaux de Paris, Hôpital Saint Louis, Hemato-oncologie, Paris, France. catherine.thieblemont@aphp.fr.ORCID http://orcid.org/0000-0002-9941-2448

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41507382
PMCPMC13056516

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.